Patent ID: 7205321
Filing Date: 2007-04-17
Classification: A61P,C07D

Abstract:
1. A compound is represented by the following structural formula: and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) X is selected from the group consisting of an optionally substituted C (b) R3 is selected from the group consisting of H, C (c) R4 is selected from the group consisting of H, a substituted or unsubstituted group selected from the group consisting of C (d) V is selected from the group consisting of a bond and a unsubstituted or substituted C1–C3 alkylene group; and (e) R6, R21, R22, R23 and R23 are each independently selected from the group consisting of H, OH, C1–C5 alkyl, alkoxy, halo, haloalkyl, haloalkoxy, nitro, phenyl, aryloxy, SO2R7, SR7, cyano, benzyloxy, phenoxy, alkylcarboxamido; or COOH wherein R7 is an alkyl or a haloalkyl.